Research Article
The Prognostic Utility of Plasma NGAL Levels in ST Segment Elevation in Myocardial Infarction Patients
Table 2
Angiographic, clinical, and biochemical properties of patients in preserved EF and reduced EF groups.
| | | Preserved LVEF, n = 34 | Reduced LVEF, n = 34 | value |
| | Female sex, n (%) | 6 (17.6) | 6 (17.6) | 0.62 | | Age, years | 56.24 ± 13.57 | 66.79 ± 14.09 | 0.002 | | DM, n (%) | 7 (20.6) | 5 (14.7) | 0.37 | | HT, n (%) | 12 (35.3) | 17 (50) | 0.16 | | DL, n (%) | 4 (11.8) | 4 (11.8) | 0.64 | | Smoking, n (%) | 24 (70.6) | 27 (79.4) | 0.28 | | Family history of CAD, n (%) | 6 (17.6) | 3 (9.1) | 0.25 | | Admission time (hours) | 3.76 ± 2.84 | 5.45 ± 2.88 | 0.01 | | Admission SBP (mmHg) | 122.79 ± 19.89 | 107.06 ± 22.63 | 0.003 | | Myocardial infarction localization | | | | | Anterior wall, n (%) | 2 (5.9) | 23 (67.6) | <0.001 | | Inferior wall, n (%) | 26 (76.5) | 7 (20.6) | | Posterior wall, n (%) | 6 (17.6) | 4 (11.8) | | Primer PCI, n (%) | 18 (52.9) | 22 (64.7) | 0.23 | | Fibrinolytic administration, n (%) | 15 (44.1) | 15 (44.1) | 0.59 | | NGAL (ng/ml) | 124 (9–382) | 184 (21–694) | 0.07 | | Troponin I (ng/ml) | 0.92 (0.13–25.00) | 3.77 (0.10–25.00) | 0.008 | | CKMB (ng/ml) | 6.60 (1.63–284.00) | 29.92 (1.81–380.00) | 0.002 | | CRP (mg/dl) | 0.27 (0.05–5.53) | 1.38 (0.44–9.59) | <0.001 | | Creatinine (mg/dl) | 0.81 ± 0.15 | 0.96 ± 0.21 | 0.001 | | GFR (ml/min) | 111.76 ± 18.64 | 91.17 ± 23.14 | <0.001 | | LDL (mg/dl) | 115.52 ± 37.28 | 133.18 ± 29.90 | 0.03 | | HDL (mg/dl) | 34.69 ± 9.11 | 38.61 ± 8.67 | 0.07 | | Haemoglobin (mg/dl) | 14.68 ± 2.19 | 14.98 ± 2.37 | 0.60 | | Leukocytes (K/uL) | 11.53 ± 3.72 | 13.05 ± 5.05 | 0.16 | | Platelets (K/uL) | 241 (72–428) | 228 (80–485) | 0.37 | | Neutrophils (K/uL) | 8.07 ± 3.45 | 9.97 ± 4.48 | 0.05 | | Lymphocytes (K/uL) | 2.26 ± 1.39 | 2.16 ± 1.40 | 0.77 | | Neutrophil-to-lymphocyte ratio | 3.86 (0.56–13.94) | 5.08 (0.88–19.90) | 0.28 |
|
|
Significant values are in bold. CAD, coronary artery disease; CKMB, creatine kinase MB; CRP, C-reactive protein; DL, dyslipidemia; DM, diabetes mellitus; GFR, glomerular filtration rate; HDL, high-density lipoprotein; HT, hypertension; LDL, low-density lipoprotein; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NGAL, neutrophil gelatinase-associated lipocalin; PCI, percutaneous coronary intervention; SBP, systolic blood pressure. |
